Compare EMD & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMD | TLRY |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.8M | 533.5M |
| IPO Year | 2003 | 2018 |
| Metric | EMD | TLRY |
|---|---|---|
| Price | $9.38 | $2.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $5.72 |
| AVG Volume (30 Days) | 298.5K | ★ 4.5M |
| Earning Date | 01-01-0001 | 10-08-2026 |
| Dividend Yield | ★ 10.25% | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.44 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.05 | $0.77 |
| 52 Week High | $11.30 | $15.70 |
| Indicator | EMD | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 40.85 |
| Support Level | $9.08 | $2.49 |
| Resistance Level | $9.49 | $4.91 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 71.01 | 60.98 |
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management and long term investment company. The primary investment objective of the company is to seek high current income, and the secondary objective is to seek capital appreciation.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.